Recent News

2023
2023.05.01

U.S.P.T.O. issues Notice of Allowance to Avecris for its SPRING DNA non-viral platform technology

Avecris
2022
2022.11.01

U.S. Dept. of Health and Human Services / BARDA selects Avecris to spotlight at 2022 BARDA Health Security Industry Day

LinkedIn
2022
2022.08.10

WheelsUp / BARDA collaboration selects Avecris for inaugural accelerator cohort to develop innovative biomanufacturing

Read more
2022
2022.07.21

Cystic Fibrosis Foundation awards Avecris with first ever Golden Ticket Award to advance novel non-viral platform

Read more

ABOUT US

Meet the experts
behind SPRING

Changing the course of human health.

Changing the course of human health.

© Avecris 2024
Contact